Corryn Biotechnologies Revenue and Competitors

Corryn Biotechnologies is developing a technology to fabricate and deposit biomimetic nano- and micro-fibrous wound dressings directly upon wound sites at the point of care. This technology aims to significantly reduce the drawbacks of current commercial products and their lack of regenerative properties. These dressings have been shown to be formable from several different material platforms both with and without additives known to be beneficial to wound healing. Our technology comprises an in-house developed handheld applicator device, loaded with sealed sterile cartridges of proprietary material formulations which are converted to fibrous substrates through a process known as electrospinning and deposited painlessly onto the patient.